Literature DB >> 28533943

Etiology and treatment of amyotrophic lateral sclerosis.

Hernando Rafael1, Juan Oscar David2, Antonio Santiago Vilca3.   

Abstract

BACKGROUND: To date all researchers conclude that the etiology of Amyotrophic lateral sclerosis (ALS) is not known. On the contrary, since August 2009, we believe that disease is of ischemic origin in the anterior surface of the medulla oblongata. MATERIAL AND
METHOD: We present our surgical experience into 45 patients with ALS (bulbar form in 36 cases and spinal form in 9). Preoperative MRI scans revealed microinfarcts in the medulla oblongata and/or cervical cord. During surgery we found: 1) poor quality of omentum in most cases; 2) degenerative changes in the cervical spine; 3) anatomical anomalies at the V4 segments of the vertebral arteries; 4) moderate to severe atherosclerosis at both V4 segments; 5) unilateral absence or stenosis in the anterior-ventral spinal arteries (AVSAs). All patients received omentum on the anterior, lateral and posterior surface of the medulla oblongata, and in 9 cases, an additional segment at the C5-C6 level.
RESULTS: Neurological improvement was better during the first days or weeks after surgery than in the following months or years, in all patients. However, 13 patients suffered neurological impairment in about 4 months later, due to greater deterioration of the cervical spine, by contrast, 7 patients with mild ALS have experienced neurological improvement by 80 to 100% during a follow-up of 4 and 6 years.
CONCLUSIONS: These results confirm that ALS is of ischemic origin in the intraparenchymal territory of the AVSAs and/or in anterior spinal artery caused by atherosclerosis and associated to anatomical variants in the V4 segments of the vertebral arteries. Because in contrast to this, its revascularization by means of omentum can cure (mild degree) or improve this disease.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; anterior spinal artery; anteriorventral spinal arteries; cervical degenerative changes; cervical spondylotic myelopathy; omental transplantation

Year:  2017        PMID: 28533943      PMCID: PMC5435608     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  24 in total

Review 1.  Amyotrophic lateral sclerosis.

Authors:  L P Rowland; N A Shneider
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

2.  Cerebral atherosclerosis and oxidative stress in Alzheimer's disease.

Authors:  Hernando Rafael
Journal:  J Alzheimers Dis       Date:  2003-12       Impact factor: 4.472

3.  Anatomical variations of the V2 segment of the vertebral artery.

Authors:  Michaël Bruneau; Jan F Cornelius; Vincent Marneffe; Michel Triffaux; Bernard George
Journal:  Neurosurgery       Date:  2006-07       Impact factor: 4.654

4.  Complications in anterior cervical discectomy and fusion for cervical degenerative disc disease.

Authors:  Leónidas M Quintana
Journal:  World Neurosurg       Date:  2013-09-27       Impact factor: 2.104

Review 5.  Omental transplantation for neurodegenerative diseases.

Authors:  Hernando Rafael
Journal:  Am J Neurodegener Dis       Date:  2014-09-06

6.  A comparative study of cerebral atherosclerosis in males and females.

Authors:  G C Flora; A B Baker; R B Loewenson; A C Klassen
Journal:  Circulation       Date:  1968-11       Impact factor: 29.690

7.  Vertebral artery in relationship to C1-C2 vertebrae: an anatomical study.

Authors:  Francesco Cacciola; Umesh Phalke; Atul Goel
Journal:  Neurol India       Date:  2004-06       Impact factor: 2.117

8.  Omental transplantation in a patient with mild ALS.

Authors:  Hernando Rafael
Journal:  Am J Neurodegener Dis       Date:  2016-07-06

Review 9.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-06-01

10.  Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.

Authors:  Bayani Uttara; Ajay V Singh; Paolo Zamboni; R T Mahajan
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.